Laboratory Operations At Diagnostic Sampling Tool Manufacturer Qiagen NV

An employee packages Qiagen QIAxcel deoxyribonucleic acid (DNA) screening kits at the manufacturing facility of Qiagen NV in Hilden, Germany, on Friday, Aug. 22, 2014. Qiagen investors are betting the busiest year for health-care deals in more than a decade will lure acquirers to one of the industry's most expensive targets. Photographer: Jasper Juinen/Bloomberg via Getty Images
An employee packages Qiagen QIAxcel deoxyribonucleic acid (DNA) screening kits at the manufacturing facility of Qiagen NV in Hilden, Germany, on Friday, Aug. 22, 2014. Qiagen investors are betting the busiest year for health-care deals in more than a decade will lure acquirers to one of the industry's most expensive targets. Photographer: Jasper Juinen/Bloomberg via Getty Images
Laboratory Operations At Diagnostic Sampling Tool Manufacturer Qiagen NV
KÖP EN LICENS
Hur får jag använda den här bilden?
kr 4,200.00
SEK

INFORMATION

Begränsningar:
Kontakta ditt lokala kontor för all kommersiell eller marknadsföringsrelaterad användning.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Upphovsman:
Bloomberg / Contributor
Redaktionell fil nr:
453958826
Samling:
Bloomberg
Datum skapat:
22 augusti 2014
Uppladdningsdatum:
Licenstyp:
Rättighetsskyddat
Releaseinformation:
Saknar release. Mer information
Källa:
Bloomberg
Objektnamn:
GERMANY QIAGEN